Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.92 USD | +0.45% | +5.62% | -27.59% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.59% | 1.49B | |
-14.52% | 11.48B | |
+44.03% | 3.27B | |
-33.09% | 2.2B | |
-18.60% | 2.05B | |
+17.10% | 1.01B | |
-3.06% | 743M | |
-33.50% | 413M | |
-46.94% | 377M | |
+27.44% | 374M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Raymond James Adjusts Veracyte's Price Target to $31 from $30 Keeps Outperform Rating